Market Overview

Benzinga's Top #PreMarket Gainers

Related HZNP
POZEN Announces Receipt Of Three Patents From The United States Patent And Trademark Office
Horzion Pharma Presents Results of ACTIMMUNE(R) Phase 2 Data, Says Results Show Statistical Significant
Horizon Inks $660M Reverse Merger With Ireland's Vidara (Fox Business)
Related EXAS
Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 3
Big Short Interest On These 5 Biotech Stocks
Making Money With Charles Payne: 11/24/14 (Fox Business)

Horizon Pharma (NASDAQ: HZNP) surged 20.91% to $17.75 in the pre-market session after the company announced its plans to acquire privately held Vidara Therapeutics International for around $660 million.

Exact Sciences (NASDAQ: EXAS) surged 10.26% to $15.90 in pre-market trading following the published results of colon cancer screening test.

Compugen (NASDAQ: CGEN) shares gained 4.37% to $11.95 in the pre-market after Jefferies initiated coverage on the stock with a Buy rating and a $17.00 price target.

Juniper Networks (NYSE: JNPR) shares jumped 2.51% to $26.56 in pre-market trading after Wells Fargo upgraded the stock from Market Perform to Outperform.

Posted-In: PreMarket GainersNews Pre-Market Outlook Markets Movers


Related Articles (CGEN + EXAS)

Around the Web, We're Loving...

Get Benzinga's Newsletters